How much is Ally Therapeutics worth in 2026?

Ally Therapeutics has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has Ally Therapeutics raised?

Ally Therapeutics has raised N/A in total funding across 1 funding rounds.

Ally Therapeutics

Drug Discovery

Ally Therapeutics valuation and funding history | Last updated: January 1, 2018 | 1 funding rounds

Current Valuation

N/A

As of January 1, 2018

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Jan 2018

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 1, 2018	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Ally Therapeutics is currently valued at N/A as of January 1, 2018.

Track Ally Therapeutics Valuation Updates

Get notified when Ally Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Ally Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Ally Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Ally Therapeutics Worth in 2026?

Ally Therapeutics is a leading private company in the Drug Discovery sector. Track Ally Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Ally Therapeutics Valuation is Determined

Private company valuations like Ally Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.